基本信息 产品详情 公司简介 推荐产品
网站主页 N-十八烷酰基 - 神经酰胺三己酯 C18 Globotriaosylceramide (d18:1/18:0)
  • C18 Globotriaosylceramide (d18:1/18:0)|T37439|TargetMol

C18 Globotriaosylceramide (d18:1/18:0)|T37439|TargetMol

C18 Globotriaosylceramide (d18:1/18:0)
8530 500μg 起订
上海 更新日期:2026-05-08

TargetMol 中国(陶术生物)

VIP1年
联系人:邵经理
电话:400-821-0310拨打
手机:15002144251 拨打
邮箱:xuexiang.shao@tsbiochem.com

产品详情:

中文名称:
C18 Globotriaosylceramide (d18:1/18:0)
英文名称:
C18 Globotriaosylceramide (d18:1/18:0)
CAS号:
69283-33-6
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
T37439

Product Introduction

Bioactivity

名称C18 Globotriaosylceramide (d18:1/18:0)
描述C18 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from lactosylceramide . It inhibits aggregation of human neutrophils induced by phorbol 12-myristate 13-acetate (PMA; 10008014) when used at a concentration of 1 μM. C18 globotriaosylceramide acts as a receptor for Shiga toxin in B cell-derived Raji cells and THP-1 monocytes. It accumulates in the brain, heart, kidney, liver, lung, and spleen in a mouse model of Fabry disease, a lysosomal storage disorder characterized by a deficiency in the enzyme α-galactosidase A. C18 globotriaosylceramide also accumulates in endothelial cells, pericytes, vascular smooth muscle cells, renal epithelial cells, dorsal ganglia neuronal cells, and myocardial cells in patients with Fabry disease.
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
溶解度Chloroform:Methanol (2:1) : Soluble
DMSO : Soluble
关键字d18:1/18:0 | C-18 Globotriaosylceramide (d18:1/18:0) | C18 Globotriaosylceramide (d18:1/18:0) | C18 Globotriaosylceramide
br
C18 Globotriaosylceramide (d18:1/18:0)|TargetMol

公司简介


成立日期 (14年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生物化工,化学试剂,生物技术服务

C18 Globotriaosylceramide (d18:1/18:0)相关厂家报价

内容声明
拨打电话 立即询价